Molecular Immunology Core
分子免疫学核心
基本信息
- 批准号:10622125
- 负责人:
- 金额:$ 54.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-23 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AddressAllograft ToleranceAnimalsAutomobile DrivingBioinformaticsBiologicalBiological AssayBone MarrowBostonCellsClinicClone CellsCollaborationsComplexComputer AnalysisComputer softwareCytomegalovirusDana-Farber Cancer InstituteData SetDevelopmentDisparityEnsureFlow CytometryGeneral HospitalsGraft RejectionHospitalsHuman Herpesvirus 4ImmuneImmune ToleranceImmune responseImmune systemImmunityImmunogeneticsImmunologic MonitoringImmunologyImmunology procedureInformation ManagementLeadLinkLungLung TransplantationMacacaMacaca fascicularisMacaca mulattaMassachusettsMethodologyMinnesotaMolecularMolecular AnalysisMolecular ImmunologyMonitorOutcomePathway interactionsPediatric HospitalsPerformancePhysiciansProceduresRegimenReproducibilityResearchResearch PersonnelSafetySamplingScientistStainsStandardizationSystemSystems AnalysisT cell infiltrationT-LymphocyteTechniquesTranslatingTransplant RecipientsTransplantationTransplantation ToleranceUniversitiesViralVirusVirus LatencyWomanbioinformatics pipelinecell typeclinically relevantdata managementexperimental studyhigh dimensionalitylung allograftmedical schoolsnovelnovel strategiesnovel therapeutic interventionsingle-cell RNA sequencingspatiotemporalsynergismtooltranscriptomicsviral detectionvirology
项目摘要
CORE SUMMARY / ABSTRACT
The MIC will provide a centralized hub for advanced cellular and systems immunological analysis of all biologic
samples derived from Projects 1-2. In addition, the MIC will coordinate and streamline all common assays and
procedures to ensure that both Projects utilize uniform Standard Operating Procedures (SOPs) and best practices.
The MIC is comprised of five interacting sub-Cores: (1) The MHC Immunogenetics and Typing Core; (2) the Flow
Cytometry and CyTOF Core; (3) The Virology and Functional Protective Immunity Core; (4) The Molecular Immunology
and Transcriptomics Core; and (5) The Computational Analysis Core. Each Core addresses an essential requirement
for the optimal conduct of the complex experiments that are proposed in Projects 1-2 and promotes collaboration
between investigators. As such, the MIC will significantly increase the efficiency and the rigor with which our group is
able to execute the lung transplant tolerance experiments proposed in this U19.
核心摘要 /摘要
麦克风将为所有生物学的高级细胞和系统免疫分析提供集中式枢纽
从项目1-2得出的样本。此外,麦克风将协调和简化所有常见测定法和
确保两个项目都使用统一的标准操作程序(SOP)和最佳实践的程序。
MIC由五个相互作用的子核组成:(1)MHC免疫遗传学和打字核心; (2)流
细胞仪和核心核心; (3)病毒学和功能保护性免疫核心; (4)分子免疫学
和转录组核心; (5)计算分析核心。每个核心都解决了基本要求
为了获得项目1-2中提出的复杂实验的最佳行为并促进协作
在调查人员之间。因此,麦克风将大大提高我们小组的效率和严格性
能够执行U19中提出的肺移植耐受实验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leslie S Kean其他文献
Leslie S Kean的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leslie S Kean', 18)}}的其他基金
Project 2: The New Era of Cellular Therapies For Lung Transplant Tolerance
项目 2:肺移植耐受细胞疗法的新时代
- 批准号:
10622128 - 财政年份:2023
- 资助金额:
$ 54.76万 - 项目类别:
Defining the T Cell Mediators of Clinical Response in Chronic GVHD
定义慢性 GVHD 临床反应的 T 细胞介质
- 批准号:
10698167 - 财政年份:2022
- 资助金额:
$ 54.76万 - 项目类别:
Defining the T Cell Mediators of Clinical Response in Chronic GVHD
定义慢性 GVHD 临床反应的 T 细胞介质
- 批准号:
10493799 - 财政年份:2022
- 资助金额:
$ 54.76万 - 项目类别:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
项目 2:用于心脏同种异体移植耐受的下一代混合嵌合诱导
- 批准号:
10270361 - 财政年份:2021
- 资助金额:
$ 54.76万 - 项目类别:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
项目 2:用于心脏同种异体移植耐受的下一代混合嵌合诱导
- 批准号:
10457401 - 财政年份:2021
- 资助金额:
$ 54.76万 - 项目类别:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
项目 2:用于心脏同种异体移植耐受的下一代混合嵌合诱导
- 批准号:
10673079 - 财政年份:2021
- 资助金额:
$ 54.76万 - 项目类别:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
低剂量与中剂量白消安治疗严重联合免疫缺陷移植的随机研究
- 批准号:
10474806 - 财政年份:2017
- 资助金额:
$ 54.76万 - 项目类别:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
低剂量与中剂量白消安治疗严重联合免疫缺陷移植的随机研究
- 批准号:
10683141 - 财政年份:2017
- 资助金额:
$ 54.76万 - 项目类别:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
低剂量与中剂量白消安治疗严重联合免疫缺陷移植的随机研究
- 批准号:
10474994 - 财政年份:2017
- 资助金额:
$ 54.76万 - 项目类别:
Integrated Molecular and Cellular Immunology Core
综合分子和细胞免疫学核心
- 批准号:
8705988 - 财政年份:2014
- 资助金额:
$ 54.76万 - 项目类别:
相似海外基金
Role of antigen-specific T cells in immunotherapy-associated acute interstitial nephritis and kidney allograft rejection
抗原特异性 T 细胞在免疫治疗相关急性间质性肾炎和肾同种异体移植排斥中的作用
- 批准号:
10351987 - 财政年份:2022
- 资助金额:
$ 54.76万 - 项目类别:
Role of antigen-specific T cells in immunotherapy-associated acute interstitial nephritis and kidney allograft rejection
抗原特异性 T 细胞在免疫治疗相关急性间质性肾炎和肾同种异体移植排斥中的作用
- 批准号:
10548204 - 财政年份:2022
- 资助金额:
$ 54.76万 - 项目类别:
Intestinal allograft tolerance in large animals
大型动物同种异体肠道移植耐受性
- 批准号:
10265649 - 财政年份:2020
- 资助金额:
$ 54.76万 - 项目类别:
Project 4-Animal transplant models to characterize immune and regenerative effects of alcohol
项目4-动物移植模型来表征酒精的免疫和再生作用
- 批准号:
10560563 - 财政年份:2019
- 资助金额:
$ 54.76万 - 项目类别:
Project 4-Animal transplant models to characterize immune and regenerative effects of alcohol
项目4-动物移植模型来表征酒精的免疫和再生作用
- 批准号:
10093989 - 财政年份:2019
- 资助金额:
$ 54.76万 - 项目类别: